SCHEMBL13809575

SCHEMBL13809575

Cc1ccc(CN2CCc3[nH]c4ccc(C(=O)NC5CCN(C(=O)OC(C)(C)C)CC5)cc4c3C2)cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 4/20 0.59
▸ HDAC6 Q9UBN7 4/20 0.59
▸ ACHE P22303 2/20 0.49
▸ DRD4 P21917 1/20 0.46
▸ AKR1B1 P15121 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ GAA P10253 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ PABPC1 P11940 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ TP53 P04637 1/20 0.41
▸ MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL61542 0.93 HDAC1 (0.52) HDAC1HDAC6ACHEDRD4AKR1B1
SCHEMBL61089 0.92 HDAC1 (0.53) HDAC1HDAC6ACHEDRD4AKR1B1
SCHEMBL61054 0.81 L3MBTL1 (0.49) KMT2AALDH1A1KDM4EMEN1HPGD
SCHEMBL3806595 0.81 HDAC1 (0.57) HDAC1HDAC6ACHEDRD4AKR1B1
SCHEMBL13809376 0.81 TRPV1 (0.45) KMT2AALDH1A1KDM4EMEN1NPSR1
SCHEMBL61090 0.81 HDAC1 (0.58) HDAC1HDAC6ACHEDRD4AKR1B1
SCHEMBL62750 0.80 HDAC1 (0.60) HDAC1HDAC6ACHEDRD4AKR1B1
SCHEMBL16939031 0.80 POLB (0.43) KMT2AALDH1A1KDM4EMEN1NPSR1
SCHEMBL62007 0.80 BRD3 (0.46) HDAC1HDAC6KMT2AALDH1A1GAA
SCHEMBL62772 0.80 HDAC4 (0.45) KMT2AALDH1A1KDM4EMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009076631-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS RIGEL PHARMACEUTICALS, INC. (US) 2009-06-18 — — WO disclosed
Send feedback